89BIO INC. - COMMON STOCK
11,06
21-февраля-25 15:45:00
15 мин. задержка
Акции
+0,10
+0,91%
Сегодняшний диапазон
10,88 - 11,23
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
89bio Initiates Phase 2b ENLIVEN Trial of BIO89-100 for the Treatment of NASH
10 июн 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
89bio Reports First Quarter 2021 Financial Results and Provides Corporate Update
12 май 2021 15:05:00 Источник Nasdaq GlobeNewswire
-
89bio to Present at Upcoming Investor Conferences
05 май 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
89bio Announces Plans for Phase 2b (ENLIVEN) Trial in NASH
05 апр 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
89bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
24 мар 2021 15:05:00 Источник Nasdaq GlobeNewswire
-
89bio Presents Additional Analysis of Phase 1b/2a NASH Study at the Annual ENDO 2021 Conference
20 мар 2021 10:00:00 Источник Nasdaq GlobeNewswire
-
89bio to Present at the Oppenheimer 31st Annual Healthcare Conference
11 мар 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
89bio to Participate in the H.C. Wainwright Global Life Sciences Conference
03 мар 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
89bio to Present at the 42nd Annual Raymond James Institutional Investors Conference
24 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
89bio to Present at the SVB Leerink 10ᵗʰ Annual Global Healthcare Conference
18 фев 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
89bio Provides Business Outlook for 2021
05 янв 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
89bio to Participate in the H.C. Wainwright BioConnect 2021 Conference
04 янв 2021 07:00:01 Источник Nasdaq GlobeNewswire